CytoDyn Announces Preliminary Results from 2021 Annual Meeting | Nation/World
VANCOUVER, Wash. - (BUSINESS WIRE) - Dec. November 2021--CytoDyn Inc.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
meeting
CytoDyn Announces Preliminary Results from 2021 Annual Meeting | National Business
VANCOUVER, Wash. - (BUSINESS WIRE) - Dec. November 2021--CytoDyn Inc.…
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
VANCOUVER, Wash. - (BUSINESS WIRE) - Nov. October 2021--CytoDyn Inc.…
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
VANCOUVER, Wash. - (BUSINESS WIRE) - Nov. October 2021--CytoDyn Inc.…
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
Obtain on the spot notifications when there may be information about your shares. Request your one-week free trial of StreetInsider Premium right here.
Activist group did not submit their proxies
With out the representatives of…
CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from…
VANCOUVER, Wash .-- (BUSINESS WIRE) - CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Firm”), a late-stage biotechnology firm growing Leronlimab, a CCR5 antagonist with potential for a number of therapeutic indications, introduced…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
VANCOUVER, Wash .-- (BUSINESS WIRE) - CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Firm”), a late-stage biotechnology firm growing Leronlimab, a CCR5 antagonist with potential for a number of therapeutic indications, right now…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting |…
VANCOUVER, Wash. - (BUSINESS WIRE) - Aug. October 2021--CytoDyn Inc.…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting |…
VANCOUVER, Wash. - (BUSINESS WIRE) - Aug. October 2021--CytoDyn Inc.…